DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ztg2gl/bone_fracture) has announced the addition of the "Bone Fracture - Pipeline Review, H2 2013" report to their offering.
'Bone Fracture - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bone Fracture, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bone Fracture.
- A snapshot of the global therapeutic scenario for Bone Fracture.
- A review of the Bone Fracture products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Bone Fracture pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Key Topics Covered:
Bone Fracture Overview
Pipeline Products for Bone Fracture - Overview
Pipeline Products for Bone Fracture - Comparative Analysis
Bone Fracture - Therapeutics under Development by Companies
Bone Fracture - Therapeutics under Investigation by Universities/Institutes
Bone Fracture - Pipeline Products Glance
Clinical Stage Products
Early Stage Products
Bone Fracture - Products under Development by Companies
Bone Fracture - Products under Investigation by Universities/Institutes
Bone Fracture - Companies Involved in Therapeutics Development
Bone Fracture - Therapeutics Assessment
KCB-1B - Drug Profile
Allogeneic Stem Cells - Drug Profile
AZD-2858 - Drug Profile
Bone Regeneration Project - Drug Profile
JVS-200 - Drug Profile
denosumab biosimilar - Drug Profile
Calcitonin Receptor Peptide - Drug Profile
17Beta-HSD2 Inhibitors - Drug Profile
Recombinant BMP-2 Biosimilar - Drug Profile
Nitric Oxide Synthase Antagonist - Drug Profile
Kaken Pharmaceutical Co., Ltd.
Juventas Therapeutics, Inc.
Laboratorios SALVAT S.A.
Bone Therapeutics SA
bioXPRESS Therapeutics SA
For more information visit http://www.researchandmarkets.com/research/ztg2gl/bone_fracture
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.